![Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity](https://pub.mdpi-res.com/vaccines/vaccines-10-00756/article_deploy/html/images/vaccines-10-00756-g001.png?1652268154)
Vaccines | Free Full-Text | Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity
![Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S245186542030003X-gr1.jpg)
Efficient dose-finding for drug combination studies involving a shift in study populations - ScienceDirect
![Pilot dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram Pilot dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram](https://www.researchgate.net/publication/13691289/figure/fig2/AS:601693326675987@1520466276525/Pilot-dose-ranging-study-demonstrating-the-dose-response-relationship-between-the-dose-of.png)
Pilot dose-ranging study demonstrating the dose-response relationship... | Download Scientific Diagram
![Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022 - ScienceDirect Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753422041643-gr1.jpg)
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022 - ScienceDirect
![Toxics | Free Full-Text | Interlaboratory Study on Zebrafish in Toxicology: Systematic Evaluation of the Application of Zebrafish in Toxicology’s (SEAZIT’s) Evaluation of Developmental Toxicity Toxics | Free Full-Text | Interlaboratory Study on Zebrafish in Toxicology: Systematic Evaluation of the Application of Zebrafish in Toxicology’s (SEAZIT’s) Evaluation of Developmental Toxicity](https://www.mdpi.com/toxics/toxics-12-00093/article_deploy/html/images/toxics-12-00093-g001-550.jpg)
Toxics | Free Full-Text | Interlaboratory Study on Zebrafish in Toxicology: Systematic Evaluation of the Application of Zebrafish in Toxicology’s (SEAZIT’s) Evaluation of Developmental Toxicity
![Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies | Respiratory Research | Full Text Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-017-0681-z/MediaObjects/12931_2017_681_Fig2_HTML.gif)
Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies | Respiratory Research | Full Text
![GOLDEN 6 study design. a Safety follow-up was conducted 5-7 days after... | Download Scientific Diagram GOLDEN 6 study design. a Safety follow-up was conducted 5-7 days after... | Download Scientific Diagram](https://www.researchgate.net/publication/321509214/figure/fig2/AS:568070860808192@1512450055486/GOLDEN-6-study-design-a-Safety-follow-up-was-conducted-5-7-days-after-the-Early.png)
GOLDEN 6 study design. a Safety follow-up was conducted 5-7 days after... | Download Scientific Diagram
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig7_HTML.png)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
![How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12874-018-0638-z/MediaObjects/12874_2018_638_Fig5_HTML.png)
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
![Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121014750-grabsf1.jpg)
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect
![Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2162253120300718-gr4.jpg)